The claim
රු. 75000 තිබී රු. 350 ට අඩු කල ඖෂධය දැන් රු. 84500 ක් ද?
Original publisher’s rating
False
Reviewed by FactCrescendo Sri Lanka ↗ ·
Read the original fact check ↗Original review summary
The review says the medicine previously discussed at a reduced price was Papaverine Hydrochloride, while the Rs. 84,500 pharmacy receipt was for Trastuzumab 440 mg—two different medicines. It reports that Trastuzumab typically costs around Rs. 84,000 and that no price reduction for it had been announced.[S1]
Research date:
Sources and attribution
- [S1] FactCrescendo Sri Lanka original review
Original review · Retrieved October 16, 2026
Original review: FactCrescendo Sri Lanka. Structured data compiled by Data Commons under CC BY 4.0. Publisher article content is subject to its own terms. Summaries and context are produced by PeakMetrics with AI assistance.
Updated